Literature DB >> 11815392

Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine.

Emmanuel Valjent1, Jennifer M Mitchell, Marie-Jo Besson, Jocelyne Caboche, Rafael Maldonado.   

Abstract

Behavioural and pharmacological effects of Delta9-tetrahydrocannabinol (THC) and nicotine are well known. However, the possible interactions between these two drugs of abuse remain unclear in spite of the current association of cannabis and tobacco in humans. The present study was designed to analyse the consequences of nicotine administration on THC-induced acute behavioural and biochemical responses, tolerance and physical dependence. Nicotine strongly facilitated hypothermia, antinociception and hypolocomotion induced by the acute administration of THC. Furthermore, the co-administration of sub-threshold doses of THC and nicotine produced an anxiolytic-like response in the light - dark box and in the open-field test as well as a significant conditioned place preference. Animals co-treated with nicotine and THC displayed an attenuation in THC tolerance and an enhancement in the somatic expression of cannabinoid antagonist-precipitated THC withdrawal. THC and nicotine administration induced c-Fos expression in several brain structures. Co-administration of both compounds enhanced c-Fos expression in the shell of the nucleus accumbens, central and basolateral nucleus of the amygdala, dorso-lateral bed nucleus of the stria terminalis, cingular and piriform cortex, and paraventricular nucleus of the hypothalamus. These results clearly demonstrate the existence of a functional interaction between THC and nicotine. The facilitation of THC-induced acute pharmacological and biochemical responses, tolerance and physical dependence by nicotine could play an important role in the development of addictive processes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11815392      PMCID: PMC1573143          DOI: 10.1038/sj.bjp.0704479

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  78 in total

Review 1.  The paradox of nicotinic acetylcholine receptor upregulation by nicotine.

Authors:  S Wonnacott
Journal:  Trends Pharmacol Sci       Date:  1990-06       Impact factor: 14.819

2.  Drugs which stimulate or facilitate central cholinergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in mice.

Authors:  R G Pertwee; T M Ross
Journal:  Neuropharmacology       Date:  1991-01       Impact factor: 5.250

Review 3.  Nicotine receptors in the mammalian brain.

Authors:  C W Luetje; J Patrick; P Séguéla
Journal:  FASEB J       Date:  1990-07       Impact factor: 5.191

4.  SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.

Authors:  M Rinaldi-Carmona; F Barth; M Héaulme; D Shire; B Calandra; C Congy; S Martinez; J Maruani; G Néliat; D Caput
Journal:  FEBS Lett       Date:  1994-08-22       Impact factor: 4.124

5.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA.

Authors:  L A Matsuda; S J Lolait; M J Brownstein; A C Young; T I Bonner
Journal:  Nature       Date:  1990-08-09       Impact factor: 49.962

6.  Spinal and supraspinal components of cannabinoid-induced antinociception.

Authors:  A H Lichtman; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  1991-08       Impact factor: 4.030

7.  Preproenkephalin mRNA and methionine-enkephalin content are increased in mouse striatum after treatment with nicotine.

Authors:  R K Dhatt; K P Gudehithlu; T A Wemlinger; G A Tejwani; N H Neff; M Hadjiconstantinou
Journal:  J Neurochem       Date:  1995-04       Impact factor: 5.372

8.  Induction of c-fos immunostaining in the rat brain after the systemic administration of nicotine.

Authors:  T Ren; S M Sagar
Journal:  Brain Res Bull       Date:  1992-11       Impact factor: 4.077

9.  Activation of multiple transcription factor genes by tetrahydrocannabinol in rat forebrain.

Authors:  P Mailleux; M Verslype; X Preud'homme; J J Vanderhaeghen
Journal:  Neuroreport       Date:  1994-06-02       Impact factor: 1.837

10.  Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment.

Authors:  F Rodríguez de Fonseca; M A Gorriti; J J Fernández-Ruiz; T Palomo; J A Ramos
Journal:  Pharmacol Biochem Behav       Date:  1994-01       Impact factor: 3.533

View more
  107 in total

1.  Is cannabinoid transmission involved in rewarding properties of drugs of abuse?

Authors:  Daniela Parolaro; Tiziana Rubino
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

2.  Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential.

Authors:  Sherrica Tai; William E Fantegrossi
Journal:  Curr Addict Rep       Date:  2014-06-01

Review 3.  Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives.

Authors:  Simone Tambaro; Marco Bortolato
Journal:  Recent Pat CNS Drug Discov       Date:  2012-04-01

Review 4.  Enhancement of endocannabinoid signaling and the pharmacotherapy of depression.

Authors:  Regina A Mangieri; Daniele Piomelli
Journal:  Pharmacol Res       Date:  2007-09-11       Impact factor: 7.658

Review 5.  The endocannabinoid system as a target for the treatment of cannabis dependence.

Authors:  Jason R Clapper; Regina A Mangieri; Daniele Piomelli
Journal:  Neuropharmacology       Date:  2008-07-19       Impact factor: 5.250

6.  Differential associations of combined vs. isolated cannabis and nicotine on brain resting state networks.

Authors:  Francesca M Filbey; Suril Gohel; Shikha Prashad; Bharat B Biswal
Journal:  Brain Struct Funct       Date:  2018-06-07       Impact factor: 3.270

7.  The endogenous cannabinoid system modulates nicotine reward and dependence.

Authors:  Lisa L Merritt; B R Martin; C Walters; A H Lichtman; M Imad Damaj
Journal:  J Pharmacol Exp Ther       Date:  2008-05-01       Impact factor: 4.030

Review 8.  Electronic nicotine delivery system use is related to higher odds of alcohol and marijuana use in adolescents: Meta-analytic evidence.

Authors:  Alexandra Hershberger; Eva Argyriou; Melissa Cyders
Journal:  Addict Behav       Date:  2020-01-27       Impact factor: 3.913

9.  Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol.

Authors:  Robert E Vann; Thomas F Gamage; Jonathan A Warner; Ericka M Marshall; Nathan L Taylor; Billy R Martin; Jenny L Wiley
Journal:  Drug Alcohol Depend       Date:  2008-04-01       Impact factor: 4.492

10.  Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts.

Authors:  Ziva D Cooper; Margaret Haney
Journal:  Drug Alcohol Depend       Date:  2009-05-14       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.